J&J MedTech and its subsidiary Cerenovus are recalling multiple versions of the Cerepak Detachable Coil Systems due to a higher-than-expected rate of detachment failure, according to an Oct. 2 letter sent to customers.
The issue has been linked to four serious injuries and one death as of Oct. 14. Affected products include various Uniform, Heliform and Freeform coil systems used in embolization procedures for intracranial aneurysms and other neurovascular abnormalities.
Customers were instructed to immediately stop using the devices, identify and segregate affected inventory and notify relevant clinical staff and any external facilities that received the products. No action is required for patients who have already received successful implantations.
The FDA classified the recall as Class I, the most serious type, indicating the potential for serious injury or death if use continues. There is no estimated date for the Cerepak systems’ return to market.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
